Commonly administered BCG strains including an evolutionarily early strain and evolutionarily late strains of disparate genealogy induce comparable protective immunity against tuberculosis

Vaccine

Volumn 27, Issue 3, 2009, Pages 441-445

  Horwitz, Marcus A ^a   Harth, Günter ^a   Dillon, Barbara Jane ^a   Masleša Galić, Saša ^a  

^a ROSS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BCG; Protective immunity; Tuberculosis; Vaccine

Indexed keywords

BCG VACCINE; SECRETORY PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; EVOLUTIONARY ALGORITHM; GENE OVEREXPRESSION; GENEALOGY; GUINEA PIG; LABORATORY; LUNG; MALE; MOLECULAR WEIGHT; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SPLEEN; STATISTICAL SIGNIFICANCE; STRAIN DIFFERENCE; TUBERCULOSIS;

ANIMALS; ANTIGENS, BACTERIAL; BCG VACCINE; BODY WEIGHT; COLONY COUNT, MICROBIAL; GUINEA PIGS; LUNG; MALE; MYCOBACTERIUM BOVIS; SPLEEN; TUBERCULOSIS;

EID: 57649143643     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.10.058     Document Type: Article

References (16)

1. Rodrigues L.C., Diwan V.K., and Wheeler J.G. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol 22 December (6) (1993) 1154-1158
2. Fine P.E. The BCG story: lessons from the past and implications for the future. Rev Infect Dis 2 March-April (11 Suppl) (1989) S353-S359
3. Colditz G.A., Brewer T.F., Berkey C.S., Wilson M.E., Burdick E., Fineberg H.V., et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 271 March (9) (1994) 698-702
4. Brandt L., Feino Cunha J., Weinreich Olsen A., Chilima B., Hirsch P., Appelberg R., et al. Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect Immun 70 February (2) (2002) 672-678
5. Malhotra I., Mungai P., Wamachi A., Kioko J., Ouma J.H., Kazura J.W., et al. Helminth- and bacillus calmette-guerin-induced immunity in children sensitized in utero to filariasis and schistosomiasis. J Immunol 162 June (11) (1999) 6843-6848
6. Rook G.A., Hernandez-Pando R., Dheda K., and Teng Seah G. IL-4 in tuberculosis: implications for vaccine design. Trends Immunol 25 September (9) (2004) 483-488
7. Behr M.A., Wilson M.A., Gill W.P., Salamon H., Schoolnik G.K., Rane S., et al. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284 May (5419) (1999) 1520-1523
8. Brosch R., Gordon S.V., Garnier T., Eiglmeier K., Frigui W., Valenti P., et al. Genome plasticity of BCG and impact on vaccine efficacy. Proc Natl Acad Sci USA 104 March (13) (2007) 5596-5601
9. Oettinger T., Jorgensen M., Ladefoged A., Haslov K., and Andersen P. Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree. Tuber Lung Dis 79 4 (1999) 243-250
10. Davids V., Hanekom W.A., Mansoor N., Gamieldien H., Gelderbloem S.J., Hawkridge A., et al. The effect of bacille calmette-guerin vaccine strain and route of administration on induced immune responses in vaccinated infants. J Infect Dis 193 February (4) (2006) 531-536
11. Horwitz M.A., Harth G., Dillon B.J., and Maslesa-Galic S. Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc Natl Acad Sci USA 97 December (25) (2000) 13853-13858
12. Horwitz M.A., Harth G., Dillon B.J., and Maslesa-Galic S. Extraordinarily few organisms of a live recombinant BCG vaccine against tuberculosis induce maximal cell-mediated and protective immunity. Vaccine 24 January (4) (2006) 443-451
13. Ladefoged A., Bunch-Christensen K., and Guld J. The protective effect in bank voles of some strains of BCG. Bull World Health Organ 43 1 (1970) 71-90
14. Lagranderie M.R., Balazuc A.M., Deriaud E., Leclerc C.D., and Gheorghiu M. Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains. Infect Immun 64 January (1) (1996) 1-9
15. Hart P.D., and Sutherland I. BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Br Med J 2 July (6082) (1977) 293-295 Jul 30
16. Kamath A.T., Fruth U., Brennan M.J., Dobbelaer R., Hubrechts P., Ho M.M., et al. New live mycobacterial vaccines: the Geneva consensus on essential steps towards clinical development. Vaccine 23 May (29) (2005) 3753-3761